BENEPALI sol inj 25 mg/0.5ml ser pré 4 x 0.5 ml
7680663250030
CH-66325
L04AB01
07.15.0.
Reimbursement limitations:
BENEPALI4
Substitution préparation de référence/biosimilaire
Traitement par BENEPALI exige une garantie préalable de prise en charge …
1 / 2
google
Details
- Product number
- 6632502
- CPT
- -
- Packaging group
- 4
- Unit
- Fertigspritze(n)
- Composition
- etanerceptum 25 mg, saccharum, natrii chloridum, natrii dihydrogenophosphas monohydricus, dinatrii phosphas heptahydricus, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml corresp. natrium 1.754 mg.
Articles (1)
Benepali 25 mg, Injektionslösung in einer Fertigspritze
Injektionslösung
4
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
25.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
1.754 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 417.30
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/06/2021
Authorization holder
Samsung Bioepis CH GmbH
6005 Luzern
Authorization information
- Swissmedic authorization number
- 66325
- Drug name
- Benepali, Injektionslösung in einer Fertigspritze
- Galenic form
- INLFS
- ATC Code
- L04AB01
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 10/09/2018
- Authorization expiration date
- 31/12/9999
- IT number
- 07.15.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- BENEPALI sol inj 25 mg/0.5ml ser pré 4 x 0.5 ml
- Description (DE)
- BENEPALI Inj Lös 25 mg/0.5ml Fertigspr 4 x 0.5 ml
- Market launch
- 10/11/2020
- Narcotic (BTM)
- No